You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study

Citation Tools

Article menu

Download PDFPDF

Spondyloarthritis
Original article
Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lindström U, Olofsson T, Wedrén S, et al
Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study
RMD Open 2018;4:e000762. doi: 10.1136/rmdopen-2018-000762